SYNDACTYLY

This adverse event was reported 831 times

SYNDACTYLY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 7 0.0024
1 CCR5 Co-receptor Antagonist [EPC] 4 0.0017
2 Ergot Derivative [EPC] 7 0.0014
3 Thyroid Hormone Synthesis Inhibitor [EPC] 9 0.0009
4 Prostaglandin E1 Analog [EPC] 14 0.0008
5 Vitamin K [EPC] 6 0.0007
6 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 5 0.0006
7 Mood Stabilizer [EPC] 123 0.0006
8 Anti-epileptic Agent [EPC] 121 0.0005
9 Protease Inhibitor [EPC] 22 0.0005
See all drug classes enriched for association with SYNDACTYLY